Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-45.88%EBITDA Margin
VS
Market
Sector
Industry
History
$ 2.1Close
$ 1.45 - $ 3.73 52-Week Range
Ticker Information
Ticker
WHWKCompany Name
WHITEHAWK THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQWHITEHAWK THERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
WHWK - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -9.91M | -45.88% | $ 21.6M |
| 3/31/2025 | $ 28.33M | 101.99% | $ 27.77M |
| 12/31/2024 | $ -62.88M | -242.02% | $ 25.98M |
| 9/30/2024 | $ -60.83M | -242.62% | $ 25.07M |
| 6/30/2024 | $ -64.56M | -271.09% | $ 23.82M |
| 3/31/2024 | $ -67.96M | -285.06% | $ 23.84M |
| 12/31/2023 | $ -64.9M | -266.5% | $ 24.35M |
| 9/30/2023 | $ -62.56M | -269.01% | $ 23.25M |
| 6/30/2023 | $ -60.76M | -282.09% | $ 21.54M |
| 3/31/2023 | $ -61.09M | -325.38% | $ 18.78M |
Key Performance Insights, Last 5 Years
- WHITEHAWK THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA % stands at -26.5%.
- Over the past 5 years, WHITEHAWK THERAPEUTICS INC's average EBITDA % has been -1030.91%.
- The median EBITDA % for WHITEHAWK THERAPEUTICS INC during this period was -270.05%
- WHITEHAWK THERAPEUTICS INC reached its highest EBITDA % over the past 5 years at 101.99%.
- The lowest EBITDA % recorded by WHITEHAWK THERAPEUTICS INC in the same timeframe -9745.27%
WHITEHAWK THERAPEUTICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for WHITEHAWK THERAPEUTICS INC is calculated as follows: EBITDA [ $ -3.98M ] / Revenues [ $ 15M ]
(=) EBITDA % [ -26.5% ] WHWK - EBITDA Margin, Last 5 years
-9745.27%
Minimum
Dec 31, 2021
101.99%
Maximum
Mar 31, 2025
-1030.91%
Average
-270.05%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.15% with a standard deviation of 26.84%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.98% |
| max | 97.73% |
| average | 16.15% |
| median | 14.67% |
| std | 26.84% |